Retatrutide 40mg Injection Pen is a pharmaceutical-grade preparation containing 40mg of Retatrutide, delivered via subcutaneous injection using a prefilled, multi-dose pen device. It can be used in treating Type 2 Diabetes Mellitus and Weight management. It may work as triple agonist receptor GIP/ GLP-1 and Glucagon receptor agonist that boosts insulin, reduces appetite, may allows gastric emptying, and increase energy burn.
Key Features
| About | |
| Drug Class | Incretin mimetic |
| Subclass | Triple hormone receptor agonist peptide |
| Active ingredient | Retatrutide |
| Retatrutide 40 mg | |
| Composition | Active ingredients
Inactive ingredients:
|
| Packaging Type | Multi-dose Prefilled pen injector |
| Pack Size | 1 Pen or vial |
| Dosage | 40 mg |
| Active ingredients | Retatrutide |
| Manufacturer | Alluvi Healthcare |
| Shelf Life | Two years refrigerated for unopened pens. |
| Usages | Weight Management & Type 2 Diabetes |
| Country of Origin | India |
How Does Retatrutide 40 mg work?
Retatrutide is a single peptide formulated to activate 3 metabolic hormone receptors at once:
- GLP-1 receptor agonism: Slows gastric emptying, increases satiety signals to the brain, enhances glucose-dependent insulin secretion
- GIP receptor agonism: Enhances insulin secretion and may improve fat metabolism in preclinical models
- Glucagon receptor agonism: Increases energy expenditure and hepatic fat oxidation in research settings
Retatrutide works by mimicking 3 gut/ liver hormones to increase insulin, reduce appetite, slow digestion, and raise energy burn. This triple mechanism may produce the highest weight loss.
Usage
- It can be used in dealing with Type-2 Diabetes.
- It can be used in managing weight.
Dosage
- starting at 1-2mg once weekly, with gradual increases every 4 weeks up to 12mg once weekly.
- 40mg pen: A 40mg pen would be a multi-dose device.
- Do not self-titrate. Rapid dose escalation increases risk of GI side effects and pancreatitis.
Side Effects
- Constipation
- Abdominal pain
- Decreased appetite
- Nausea
- Diarrhea
- Vomiting
- Heartburn
- Flatulence
- Redness
- Itching
- Dizziness
Interactions
- It may interact adversely with other oral medications resulting in slowing gastric emptying this can delay absorption of other oral drugs.
- It also interacts with insulin/Sulfonylureas the concomitant use increases hypoglycaemia risk.
- Warfarin monitoring is need as it may affects the absorption.
- Alcohol may lead to increase the risk of other side effects.
Pharmacokinetics
- It may reach the peak plasma concentration Tmax at just 24-72 hours post Sub injection.
- Proteolytic degradation occurs to form small peptides and amino acids, similar to other GLP-1 peptides. This is followed by metabolism.
- Excretion, via kidney.
Precautions
- Personal/family history of medullary thyroid carcinoma or MEN2.
- History of pancreatitis, gallbladder disease, or severe GI disease.
- Type 1 diabetes or diabetic ketoacidosis history.
- Severe renal impairment dehydration risk.
- Pregnancy, planning pregnancy, or breastfeeding weight loss not recommended; fetal risk unknown.
Conclusion
Retatrutide 40mg Injection Pen is a pharmaceutical-grade preparation containing 40mg of Retatrutide, delivered via subcutaneous injection using a prefilled, multi-dose pen device. It can be used in treating Type 2 Diabetes Mellitus and Weight management. It may work as triple agonist receptor GIP/ GLP-1 and Glucagon receptor agonist that boosts insulin, reduces appetite, may allow gastric emptying, and increase energy burn. It may have some side effects that may can vary side effects like vomiting, nausea, diarrhea, constipation, abdominal pain and decreased appetite. Prior taking any such dosage need to take doctors advised.
FAQs
- For what purpose Retatrutide 40 mg is used?
Retatrutide 40 mg is used in Metabolic applications like weight management and Type 2 Diabetes.
- How does Retatrutide 40 mg work?
Retatrutide 40 mg may work as triple agonist receptor GIP/ GLP-1 and Glucagon receptor agonist that boosts insulin, reduces appetite, may allow gastric emptying, and increase energy burn.
- What can be possible side effects of Retatrutide 40 mg?
The possible side effects can be vomiting, nausea, diarrhea, constipation, abdominal pain and decreased appetite.
- Who should avoid taking Retatrutide 40 mg?
The one with medical history of Medullary thyroid carcinoma (MTC) or MEN2, the one with hypersensitive to Retatrutide and Type 1 Diabetes should avoid taking any such medications.
- What can be the onset of action of Retatrutide?
It reaches the peak plasma concentration at just 24-72 hours after SubQ injection.
Note: Retatrutide is a prescription medicine and this is for educational purpose only. Please prior using any such medications consult your healthcare provider.
elise wells –
Best product i have ever taken for weight loss